Articles

Page 4 of 7

Engaging Nigerian community pharmacists in public health programs: assessment of their knowledge, attitude and practice in Enugu metropolis

The Nigerian health sector battles with control of infectious diseases and emerging non-communicable diseases. Number of healthcare personnel involved in public health programs need to be boosted to contain th...

Authors: Ogochukwu Offu, Maureen Anetoh, Matthew Okonta and Obinna Ekwunife

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:27

Content type: Research

Published on: 9 November 2015
- View Full Text
- View PDF
Improvements for international medicine donations: a review of the World Health Organization Guidelines for Medicine Donations, 3rd edition

Some humanitarian and development organizations respond to major natural disasters and emergencies by donating medicines. Many provide medicines on a routine basis to support health systems, particularly those...

Authors: Nuria Cañigueral-Vila, Jennifer C. Chen, Lindsey Frenkel-Rorden and Richard Laing

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:28

Content type: Review

Published on: 19 October 2015
- View Full Text
- View PDF
Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study

Withdrawal of conditional regulatory approval or subsidization of new medicines when subsequent evidence does not confirm early trial results may not be well understood or accepted by the public.

Authors: Agnes Vitry, Tuan Nguyen, Vikky Entwistle and Elizabeth Roughead

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:25

Content type: Research

Published on: 19 October 2015
- View Full Text
- View PDF
Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review

Hypertension is the leading modifiable cause of mortality worldwide. Unlike many conditions where limited evidence exists for management of older individuals, multiple large, robust trials have provided a soli...

Authors: Tariq M Alhawassi, Ines Krass and Lisa G Pont

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:24

Content type: Review

Published on: 14 October 2015
- View Full Text
- View PDF
Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU

Authors: Andreas Siakou and Costas Athanasakis

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P29

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines

Authors: Maarten Van Baelen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P28

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Medicines optimisation in Northern Ireland - scope and results of a challenging project

Authors: Mike Scott, Frans van Andel and Rob Brenninkmeijer

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P27

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate

Authors: Elizabeth Docteur, Joshua Cohen, Brian K Bruen, Ruth Lopert, Avi Dor and Chuck Shih

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P26

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The effective and innovative cost saving of software in managing unregistered drugs

Authors: Nur Wahida Zulkifli, Noorizan Abd Aziz, Yahaya Hassan, Mohamed Azmi Hassali and Nur Liyana Zainal Bahrin

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P25

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines

Authors: Aneta Lipińska, Maciej Pomorski, Wojciech Matusewicz and Katarzyna Jagodzińska-Kalinowska

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P24

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Pharmaceutical distribution remuneration in Europe

Authors: Sabine Vogler, Lena Lepuschütz and Peter Schneider

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P23

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Insurance-based risk-sharing agreements

Authors: Augustin Terlinden, Amine Aissaoui and Olivier Ethgen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P22

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The prices outpatients have to pay for purchasing medicines in Armenia

Authors: Irina Kazaryan, Anahit Sevikyan and Margarit Melikyan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P20

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Access of high technology medicines in Russia

Authors: Liudmila Bezmelnitsyna, Dmitry Meshkov and Ramil Khabriev

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P19

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Optimising prescribing in primary care: an evaluation of financial and clinical parameters

Authors: Asal Albayati, David Lu, Liam Sergeant, Nandita Singh, Keith Crump and Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P18

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Authors: Rossen M Kazakov and Penka I Petrova

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P17

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Prices of oncology medicines in European countries, Australia and New Zealand

Authors: Sabine Vogler, Agnes Vitry and Zaheer Ud-Bin-Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P16

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Collaborative models for increasing efficiency of early drug assessment

Authors: Anna Nachtnebel and Claudia Wild

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O15

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Value of generic medicines: an health economics study

Authors: Martin Albrecht, Ariane Höer and Anne Zimmermann

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P15

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience

Authors: Nur Liyana Zainal Bahrin, Yahaya Hassan, Abu Bakar Abd Majeed, Nur Wahida Zulkifli and Azlan Ahmad

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P14

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?

Authors: Nicola Magrini, Lorenzo Moja, Bernadette Cappello, Kees De Joncheere and Gilles Forte

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O14

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir

Authors: Hedi Schelleman, Rudy Dupree, Finn B Kristensen and Wim Goettsch

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O13

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

Authors: Christine Leopold, James D Chambers and Anita K Wagner

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P13

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities

Authors: Sabine Vogler, August Österle and Susanne Mayer

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O12

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets

Authors: Kristina Hristova and Claudia Habl

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P12

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

Authors: Yared Santa-Ana-Tellez, Veronika J Wirtz, Hubert GM Leufkens and Aukje K Mantel-Teeuwisse

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O11

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Determining the prices of the medicines in the absence of superiority over alternative medical technology

Authors: Wojciech Matusewicz, Katarzyna Jagodzińska-Kalinowska, Aneta Lipińska and Maciej Pomorski

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P11

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors

Authors: Susan Spillane, Cara Usher, Kathleen Bennett, Roisin Adams and Michael Barry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O10

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Availability and affordability of medicines for children

Authors: Irina Kazaryan and Lusine Vardanyan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P10

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results

Authors: Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri and Daniela Roggeri

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P9

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Approval, reimbursement and pricing of high-cost cancer medicines in Australia

Authors: Agnes Vitry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O9

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Policy options to deal with high-cost medicines – survey with European policy-makers

Authors: Nina Zimmermann, Sabine Vogler and Hanne Bak Pedersen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P8

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Authors: Aris Angelis and Panos Kanavos

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O8

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Developing a Drug Price Reference Index in the Philippines

Authors: Manuel A Haasis, Anna M Guerrero and Marinette J Ladioray

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P7

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework

Authors: Panos Kanavos and Aris Angelis

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O7

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Retrospective financial analysis of medicines reimbursement services in community pharmacy

Authors: Elena Chitan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P6

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences

Authors: Zaheer-Ud-Din Babar, Abdul Ali, Christine Kim, James Mcintosh, Malaika Samuel Namdas, Erica Lourdes Rodrigues, Komal Vallabh and Anne Rew

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O6

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Scottish collaboration to integrate medicine therapy between out-patient and in-patient sectors

Authors: Kenneth R Paterson

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K6

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Pharmaceutical policies in Australia and New Zealand

Authors: Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K5

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system

Authors: Dumebi O Mordi, Kwesi Eghan and Jim Rankin

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P5

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?

Authors: Anna-Theresa Renner, Julia Bobek, Herwig Ostermann, Peter Schneider and Sabine Vogler

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O5

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of delisting OTC medicines from reimbursement list

Authors: Petra Chytilová and Robin Šebesta

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P4

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of discounts on medicine prices

Authors: Peter Schneider and Sabine Vogler

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O4

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Priority medicines for Europe and the World: setting a public-health-based medicines development agenda

Authors: Veronika J Wirtz

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K4

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region

Authors: Tuan A Nguyen, Sun Qiang, Haipeng Wang, Krishna Undela and Agnes Vitry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P3

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure

Authors: Anna Lukačišinová and Helena Skácelová

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O3

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Authors: Jaana E Martikainen, Timo Maljanen, Hanna Koskinen and Sabine Vogler

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P2

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Authors: Elizabeth Docteur and Ruth Lopert

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O2

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin

Authors: Jessica Fraeyman, Hans De Loof, Guido Van Hal, Guido De Meyer, Roy Remmen and Philippe Beutels

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P1

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Financial based agreements and performance based agreements: the Belgian experience

Authors: Kim Pauwels, Isabelle Huys, Eveline Bielen, Sigrid Bormans, Robin Vincken, Henna Zheng, Minne Casteels and Steven Simoens

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O1

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF

Articles

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

Contact us